查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924633

血库及血液製品市场依产品类型、应用、最终用户及技术划分－2026-2032年全球预测

Blood Banking & Blood Products Market by Product Type, Application, End User, Technology - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血库和血液製品市场价值将达到 215 亿美元，到 2026 年将成长至 231.4 亿美元，到 2032 年将达到 392.6 亿美元，年复合成长率为 8.98%。

关键市场统计数据
基准年 2025 215亿美元
预计年份：2026年 231.4亿美元
预测年份 2032 392.6亿美元
复合年增长率 (%) 8.98%

血液银行和血液製品产业处于临床需求、技术创新和复杂供应链动态的交汇点。诊断方法、自动化和数据整合的最新进展正在改变血液的收集、检测、处理、储存和分发方式，为提高安全性、效率和患者疗效创造了新的机会。同时，人口结构的变化、择期和急诊医疗模式的演变以及对输血传播感染疾病日益增长的关注，都在持续影响着各医疗机构的运作重点。

本执行摘要提炼了影响该行业的最相关趋势，并综合分析了这些趋势对医院系统、诊断检查室和中心血库等相关人员的影响，同时为製造商、服务供应商和政策顾问提供决策指南。报告重点关注可观察的趋势，例如先进血液分离平台的应用、高灵敏度核酸扩增工作流程的出现以及监管和贸易政策变化对运营的影响，强调实用见解而非推测性预测。本报告旨在为领导者提供清晰、实用的观点，帮助他们设定投资重点、制定筹资策略策略并建立伙伴关係。

技术创新与商业需求如何整合，重塑血液製品生态系统的临床工作流程与供应链韧性

随着技术、监管和营运因素的融合，血库和血液製品产业正经历着变革性的转变。自动化数位化正从实验室工作台扩展到端到端的流程协调，从而实现更一致的成分製备和可追溯性。流式细胞技术在专业的免疫血液学应用中日益成熟，核酸扩增技术也因其灵敏的病原体检测能力而日益普及，这些因素共同提高了安全性和通量标准。

评估关税变化对血液服务供应链、筹资策略和组织韧性的多方面营运和采购影响

关税及相关贸易措施的实施对整个血库生态系统产生了显着的连锁反应，影响到设备采购、试剂采购以及跨境服务合约的经济效益。关税会增加专用设备、自动化分离器和高灵敏度检测套组的成本，这将影响血库、医院和诊断检查室的采购模式，迫使采购团队寻找替代供应商或营运补偿措施以维持服务水准。

策略性細項分析揭示了产品分类、临床应用、最终用户和诊断技术如何相互交织，从而定义产品采纳路径。

对产品层面与应用层面细分的深入理解，有助于明确临床价值与商业性机会的交会。在产品类型方面，血液分离设备涵盖白血球分离、血浆分离和血小板分离等多种模式，每种模式都针对特定的治疗和采集需求。血液采集和储存系统包含多种血袋配置，包括单袋、双袋、三袋和四袋，以满足不同的血液成分分离需求。血液成分分离设备种类繁多，从可最大限度提高通量和一致性的自动化平台，到在低通量和资源受限环境下仍然效用的手动製备装置，应有尽有。血液筛检测试包括仪器平台和试剂/试剂盒，可进一步分为免疫血液学检测、传染病筛检和核酸检测试剂。输血设备包括输注设备和加热设备，这些设备对于安全输血至关重要。

区域趋势和采购环境将决定诊断能力、管理体制和供应链如何影响全球市场的接受度。

区域趋势将对全球血液生态系统的技术应用、监管路径和供应链设计产生深远影响。在美洲，医疗系统呈现多样化的采购模式，从集中式的国家项目到分散式的医院主导采购，不一而足，这塑造了对高通量自动化和适应性强的照护现场的需求。分子诊断和捐血筛检的进步通常得益于完善的检查室基础设施和成熟的报销机制，从而为先进的核酸增幅检查（NAT）和流式细胞技术的推广应用创造了有利环境。

一体化产品服务模式和策略伙伴关係如何重新定义血液製品产业製造商和供应商的竞争优势

血液银行和血液製品产业的竞争动态正日益受到整合硬体、耗材和软体服务的综合临床解决方案的影响。领先的製造商正透过将自动化成分分离器和血球分离平台与检验的试剂组合以及简化库存管理和捐血者追踪的数位化工具相结合，来强化其价值提案。策略联盟和有针对性的收购正被用于弥补能力差距、加速进入相邻应用领域以及加强服务网路。

务实的领导优先事项包括协调采购、互通性、员工发展和来源多样性，以增强业务连续性。

行业领导者应优先考虑将技术能力与营运韧性和临床安全要求相结合的投资。首先，应强调筹资策略，在确保长期可维护性和耗材供应的同时，兼顾初始投资效率，确保设备选型得到可靠的售后服务网络和检验的试剂供应支持。其次，应选择支援标准化资料交换和实验室资讯系统整合的平台和供应商，以促进互通性，从而提高可追溯性并实现更有效的品管。

一种多层次的研究途径，结合专家对话、监管分析和技术评估，以产生经过实践验证且具有实际操作价值的见解。

本研究采用多层次调查方法进行综合分析，该方法整合了定性专家访谈、公开的监管文件、同行评审的临床文献以及主要供应商的技术资料，从而全面了解当前的行业趋势。研究人员对临床医生、实验室主任、采购专业人员和製造工程师进行了专家访谈，以确定不同营运环境下的实际限制、推广驱动因素和实施经验教训。此外，研究人员还分析了公开的监管文件和指导文件，以确定与筛检和输血安全相关的合规要求和不断发展的标准。

综合结论强调了将技术进步和供应链韧性与持续的临床结果联繫起来的实际步骤。

目前血库和血液製品产业既面临挑战，也蕴藏着实际机会。诊断灵敏度、自动化和流程整合的进步提高了安全性和效率的标准，而地缘政治和贸易趋势则凸显了建立具有韧性的供应炼和灵活采购模式的必要性。那些积极主动地将技术选择与可维护性、数据互通性和人员配备相结合的机构，将更有能力在不断变化的临床需求面前，维持高品质的输血服务。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的血库和血液製品市场

  • 血液分离机
    • 白血球分离术
    • 等离子分离器
    • 血小板分离术
  • 血液采集和储存系统
    • 双血袋
    • 四联血袋
    • 单血袋
    • 三重血袋
  • 血液成分分离装置
    • 自动血液成分分离装置
    • 手动血液成分製备套装
  • 血液筛检测试
    • 装置
    • 试剂和试剂盒
      • 免疫血液学检测
      • 传染病筛检
      • 核酸增幅检查（NAT）试剂
  • 输血设备
    • 点滴装置
    • 加热装置

9. 按应用分類的血库和血液製品市场

  • 免疫血液学
  • 分子诊断
  • 品管

第十章 以最终用户分類的血库和血液製品市场

  • 血库和捐血中心
  • 诊断检查室
  • 医院

11. 依技术分類的血库和血液製品市场

  • 流式细胞技术
  • 核酸扩增技术
  • 血清学检测

12. 按地区分類的血库和血液製品市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按群体分類的血库和血液製品市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国血库及血液製品市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国血库与血液製品市场

第十六章 中国血库与血液製品市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • American National Red Cross
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • CSL Limited
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Greiner Bio-One International GmbH
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kedrion SpA
  • LFB SA
  • Macopharma SA
  • Medline Industries, Inc.
  • Nipro Corporation
  • Octapharma AG
  • Ortho Clinical Diagnostics, Inc.
  • QIAGEN NV
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Vitalant, Inc.
Product Code: MRR-7A380DA7C3E8

The Blood Banking & Blood Products Market was valued at USD 21.50 billion in 2025 and is projected to grow to USD 23.14 billion in 2026, with a CAGR of 8.98%, reaching USD 39.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 21.50 billion
Estimated Year [2026] USD 23.14 billion
Forecast Year [2032] USD 39.26 billion
CAGR (%) 8.98%

The blood banking and blood products sector sits at the intersection of clinical necessity, technological innovation, and complex supply chain dynamics. Recent advances in diagnostic modalities, automation, and data integration have reshaped how blood is collected, tested, processed, stored, and delivered, creating new opportunities to enhance safety, efficiency, and patient outcomes. At the same time, demographic shifts, evolving patterns of elective and emergency care, and heightened attention to transfusion-transmissible infections continue to influence operational priorities across institutions.

This executive summary distills the most pertinent developments shaping the sector, synthesizes implications for stakeholders across hospital systems, diagnostic laboratories, and centralized blood banks, and highlights decision levers for manufacturers, service providers, and policy advisors. The narrative emphasizes practical insights over speculative projection, focusing on observable trends such as the adoption of advanced apheresis platforms, the emergence of high-sensitivity nucleic acid amplification workflows, and the operational impact of regulatory and trade policy shifts. The goal is to equip leaders with clear, actionable perspectives that support investment prioritization, procurement strategy, and partnership formation.

How converging technological innovations and operational imperatives are reshaping clinical workflows and supply chain resilience across the blood products ecosystem

The landscape of blood banking and blood products is undergoing transformative shifts driven by converging technological, regulatory, and operational forces. Automation and digitalization have expanded beyond laboratory benchtops into end-to-end process orchestration, enabling more consistent component preparation and traceability. Flow cytometry has matured for specialized immunohematology applications while nucleic acid amplification techniques are gaining traction for high-sensitivity pathogen detection, collectively raising the bar for safety and throughput.

Simultaneously, modular and scalable apheresis platforms are enabling blood centers to respond dynamically to changing donor availability and therapeutic demand patterns. The integration of improved reagents and point-of-care immunohematology instruments is reducing turnaround times and enabling decentralized testing models that can relieve pressure on centralized laboratories. In parallel, warming devices and infusion technologies are being refined to support complex transfusion scenarios in ambulatory and inpatient settings.

These technological shifts intersect with operational imperatives. Institutional emphasis on supply chain resilience, inventory optimization, and donor recruitment strategies is prompting investments in collection and storage systems that can accommodate variable demand. As stakeholders implement these innovations, attention to interoperability, data governance, and workforce training becomes critical to translate capability into consistent, measurable improvements in patient care.

Assessing the multifaceted operational and procurement consequences of tariff changes on supply chains, sourcing strategies, and institutional resilience in blood services

The imposition of tariffs and associated trade measures can create substantive ripple effects across the blood banking ecosystem, affecting equipment procurement, reagent sourcing, and the economics of cross-border service arrangements. Tariffs that elevate the cost of specialized instruments, automated separators, and high-sensitivity testing kits influence buying patterns among blood banks, hospitals, and diagnostic laboratories, with procurement teams seeking either alternative suppliers or operational offsets to preserve service levels.

In response to tariff-driven cost pressures, some institutions may extend equipment replacement cycles, defer noncritical upgrades, or consolidate purchasing through group procurement vehicles to maintain access to essential technologies. Others might pursue deeper technical validation of domestic alternatives or prioritize instrument-agnostic reagent portfolios to mitigate exposure. Tariff effects also accelerate conversations about local manufacturing and nearshoring for critical components and consumables, which in turn reshape supplier selection criteria and contract negotiation strategies.

Operationally, increased import costs can heighten the focus on process efficiencies and yield optimization, prompting investments in component separators and collection systems that maximize usable output per donation. Regulatory compliance continues to be a central consideration as institutions balance cost mitigation with the imperative to meet established safety standards. Overall, tariff-related changes amplify the need for flexible procurement strategies, robust supplier risk assessments, and contingency planning to ensure uninterrupted patient services.

Strategic segmentation analysis revealing how product classes, clinical applications, end users, and diagnostic technologies intersect to define adoption pathways

A nuanced understanding of product-level and application-focused segmentation clarifies where clinical value and commercial opportunity converge. Within product types, apheresis equipment spans modalities such as leukapheresis, plasma apheresis, and platelet apheresis, each serving discrete therapeutic and collection priorities; blood collection and storage systems encompass diverse bag configurations including single, double, triple, and quadruple blood bags that respond to component separation needs; blood component separators range from automated platforms that maximize throughput and consistency to manual preparation sets that retain relevance in lower-volume or resource-constrained environments. Blood screening tests comprise instrument platforms and reagents and kits, with reagents further differentiated across immunohematology testing, infectious disease screening, and nucleic acid testing reagents, and blood transfusion equipment incorporates infusion devices and warming devices critical for safe delivery.

Application segmentation delineates contexts of use such as immunohematology, molecular diagnostics, and quality control workflows, where each application imposes distinct technical and regulatory requirements that influence procurement and operational priorities. End user segmentation highlights the different buyer behaviors and operational imperatives of blood banks and donation centers, diagnostic laboratories, and hospitals, each of which balances cost, throughput, and clinical risk in unique ways. Technology segmentation-covering flow cytometry, nucleic acid amplification technology, and serological testing-underscores the importance of aligning platform selection with diagnostic sensitivity, throughput demands, and compatibility with existing laboratory information systems.

Bringing these dimensions together reveals differentiated pathways for adoption and investment. High-throughput automated separators and NAT-capable screening workflows tend to align with centralized blood bank strategies focused on yield and risk mitigation, whereas single or manual collection systems paired with serological testing maintain relevance for decentralized or low-resource settings. Immunohematology solutions that integrate flow cytometry provide advanced antigen profiling capabilities for complex transfusion management, while smaller hospitals may prioritize robust infusion and warming devices to support bedside transfusion safety. The interplay of product type, application, end user, and technology creates a mosaic of requirements that suppliers and purchasers must navigate to optimize clinical outcomes and operational efficiency.

Regional dynamics and procurement environments that determine how diagnostic capabilities, regulatory regimes, and supply chains shape adoption across global markets

Regional dynamics exert a profound influence on technology adoption, regulatory pathways, and supply chain design across the global blood ecosystem. In the Americas, healthcare systems exhibit diverse procurement models spanning centralized national programs to decentralized hospital-driven purchasing, which shapes demand for both high-throughput automation and adaptable point-of-care solutions. Progress in molecular diagnostics and donor screening is often supported by strong laboratory infrastructure and established reimbursement pathways, creating an environment in which advanced NAT and flow cytometry implementations can scale.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying investment capacities result in differentiated adoption patterns. Some European markets prioritize harmonized standards and robust pharmacovigilance, encouraging deployment of automated component separators and integrated screening platforms, while parts of the Middle East and Africa focus investments on expanding basic collection and storage capabilities and improving access to essential reagents. These differences amplify the importance of supplier models that combine technology transfer, local training, and flexible commercial terms.

In the Asia-Pacific region, rapid healthcare infrastructure expansion, growing clinical demand, and targeted investments in biotechnology are driving increased uptake of advanced screening technologies and automated processing equipment. The region also presents a complex mix of centralized and decentralized procurement environments, with opportunities for manufacturers that can offer scalable solutions and localized service networks. Across all regions, local regulatory frameworks, donor demographics, and logistics considerations inform decisions on equipment standardization, reagent sourcing, and strategic partnerships.

How integrated product-service models and strategic partnerships are redefining competitive advantage for manufacturers and suppliers in the blood products sector

Competitive dynamics in the blood banking and blood products sector are increasingly defined by the integration of hardware, consumables, and software services into cohesive clinical solutions. Leading manufacturers are enhancing value propositions by coupling automated component separators and apheresis platforms with validated reagent portfolios and digital tools that streamline inventory management and donor traceability. Strategic alliances and targeted acquisitions are being used to fill capability gaps, accelerate entry into adjacent application areas, and strengthen service networks.

Companies that can demonstrate strong post-sale support, rapid access to consumables, and clear regulatory positioning hold a distinct advantage in procurement conversations. The ability to offer instrument-agnostic reagents and kits, backed by robust clinical validation, reduces switching costs for end users and opens cross-selling opportunities. In parallel, vendors emphasizing modularity and scalability in equipment design address the needs of both large centralized blood centers and smaller hospitals seeking predictable operational economics.

Service differentiation is also emerging through digital enablement, including analytics that optimize donor recruitment and component utilization, as well as remote diagnostics that reduce downtime and improve uptime guarantees. These capabilities are increasingly decisive in procurement evaluations, influencing long-term relationships and shaping the evolution of supplier landscapes.

Actionable leadership priorities that align procurement, interoperability, workforce development, and sourcing diversification to strengthen operational continuity

Industry leaders should prioritize investments that align technological capability with operational resilience and clinical safety imperatives. First, emphasize procurement strategies that balance long-term serviceability and consumable availability with initial capital efficiency, ensuring that equipment choices are supported by reliable post-sale service networks and validated reagent supplies. Second, advance interoperability by selecting platforms and vendors that support standardized data exchange and laboratory information system integration, thereby improving traceability and enabling more effective quality control.

Third, consider diversifying sourcing strategies to reduce exposure to single points of failure in global supply chains, including evaluating nearshoring options for critical reagents and consumables where feasible. Fourth, invest in workforce development and change management to ensure that the benefits of automation and new diagnostics translate into consistent clinical practice, focusing on competency frameworks and competency assessments. Fifth, prioritize participation in collaborative initiatives with regulators and peer institutions to harmonize testing standards and accelerate adoption of evidence-based screening protocols. These combined actions will strengthen operational continuity while enabling incremental adoption of high-impact technologies.

A layered research approach combining expert engagement, regulatory analysis, and technical evaluation to produce validated, operationally relevant insights

This research synthesis draws upon a layered methodology that integrates qualitative expert interviews, public regulatory documentation, peer-reviewed clinical literature, and primary supplier technical materials to create a comprehensive picture of current sector dynamics. Expert interviews were conducted with clinicians, laboratory directors, procurement specialists, and manufacturing technologists to surface practical constraints, adoption drivers, and implementation lessons across diverse operational settings. Public regulatory filings and guidance documents were analyzed to identify compliance requirements and evolving standards relevant to screening and transfusion safety.

Technical evaluation of equipment and reagents incorporated manufacturer specifications, independent validation studies, and where available, comparative performance assessments to illuminate trade-offs among throughput, sensitivity, and maintenance requirements. Operational implications were synthesized by mapping technology characteristics onto institutional workflows, enabling the development of actionable recommendations that are grounded in real-world constraints. Throughout, care was taken to ensure transparency of source types and to triangulate findings across multiple evidence streams to enhance reliability and relevance for decision-makers.

Consolidated conclusions emphasizing practical steps to translate technological advances and supply chain resilience into consistent clinical outcomes

The current environment for blood banking and blood products presents both challenges and tangible opportunities. Advances in diagnostic sensitivity, automation, and process integration are elevating standards for safety and efficiency, while geopolitical and trade developments underscore the need for resilient supply chains and flexible procurement models. Institutions that proactively align technology selection with serviceability, data interoperability, and workforce readiness will be better positioned to sustain high-quality transfusion services in the face of evolving clinical demands.

Moving forward, stakeholders should focus on pragmatic steps that reduce operational variability and enhance responsiveness, such as strengthening supplier relationships, expanding local capacity for critical consumables where possible, and investing in diagnostic platforms that balance accuracy with usability. The practical synthesis offered here is intended to support clear decision-making by executives, clinical leaders, and procurement professionals as they navigate a dynamic landscape that requires both immediate operational attention and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Banking & Blood Products Market, by Product Type

  • 8.1. Apheresis Equipment
    • 8.1.1. Leukapheresis
    • 8.1.2. Plasma Apheresis
    • 8.1.3. Platelet Apheresis
  • 8.2. Blood Collection And Storage Systems
    • 8.2.1. Double Blood Bag
    • 8.2.2. Quadruple Blood Bag
    • 8.2.3. Single Blood Bag
    • 8.2.4. Triple Blood Bag
  • 8.3. Blood Component Separators
    • 8.3.1. Automated Component Separators
    • 8.3.2. Manual Component Preparation Sets
  • 8.4. Blood Screening Tests
    • 8.4.1. Instruments
    • 8.4.2. Reagents And Kits
      • 8.4.2.1. Immunohematology Testing
      • 8.4.2.2. Infectious Disease Screening
      • 8.4.2.3. NAT Reagents
  • 8.5. Blood Transfusion Equipment
    • 8.5.1. Infusion Devices
    • 8.5.2. Warming Devices

9. Blood Banking & Blood Products Market, by Application

  • 9.1. Immunohematology
  • 9.2. Molecular Diagnostics
  • 9.3. Quality Control

10. Blood Banking & Blood Products Market, by End User

  • 10.1. Blood Banks And Donation Centers
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals

11. Blood Banking & Blood Products Market, by Technology

  • 11.1. Flow Cytometry
  • 11.2. Nucleic Acid Amplification Technology
  • 11.3. Serological Testing

12. Blood Banking & Blood Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Banking & Blood Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Banking & Blood Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Banking & Blood Products Market

16. China Blood Banking & Blood Products Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. American National Red Cross
  • 17.7. Asahi Kasei Corporation
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Bio-Rad Laboratories, Inc.
  • 17.11. Cardinal Health, Inc.
  • 17.12. CSL Limited
  • 17.13. Danaher Corporation
  • 17.14. F. Hoffmann-La Roche AG
  • 17.15. Fresenius SE & Co. KGaA
  • 17.16. Greiner Bio-One International GmbH
  • 17.17. Grifols, S.A.
  • 17.18. Haemonetics Corporation
  • 17.19. Immucor, Inc.
  • 17.20. Kedrion S.p.A.
  • 17.21. LFB S.A.
  • 17.22. Macopharma S.A.
  • 17.23. Medline Industries, Inc.
  • 17.24. Nipro Corporation
  • 17.25. Octapharma AG
  • 17.26. Ortho Clinical Diagnostics, Inc.
  • 17.27. QIAGEN N.V.
  • 17.28. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 17.29. Takeda Pharmaceutical Company Limited
  • 17.30. Terumo Corporation
  • 17.31. Thermo Fisher Scientific Inc.
  • 17.32. Vitalant, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 206. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 239. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 250. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)